vs
Arcturus Therapeutics Holdings Inc.（ARCT）与Valaris Ltd（VAL）财务数据对比。点击上方公司名可切换其他公司
Arcturus Therapeutics Holdings Inc.的季度营收约是Valaris Ltd的1.4倍（$7.2M vs $5.2M），Valaris Ltd同比增速更快（405.9% vs -68.4%），Valaris Ltd自由现金流更多（$-34.1M vs $-74.5M），过去两年Valaris Ltd的营收复合增速更高（29.5% vs -56.5%）
Arcturus Therapeutics Holdings Inc.是一家专注于RNA药物研发的美国生物科技企业，核心业务覆盖罕见病与传染病领域药物的研发、开发与商业化。该公司自主研发了专属脂质纳米颗粒递送技术，可用于递送小干扰RNA、信使RNA、基因编辑RNA、DNA、反义寡核苷酸、微小RNA等多种核酸药物。
瓦拉瑞斯有限公司是全球领先的海上钻井承包商，总部位于美国得克萨斯州休斯敦，注册地为百慕大，是全球规模最大的海上钻井及油井钻井服务企业。截至2025年2月，公司共运营52座钻井平台，包含36座海上自升式钻井平台、11艘钻井船以及5座半潜式钻井平台。
ARCT vs VAL — 直观对比
营收规模更大
ARCT
是对方的1.4倍
$5.2M
营收增速更快
VAL
高出474.3%
-68.4%
自由现金流更多
VAL
多$40.4M
$-74.5M
两年增速更快
VAL
近两年复合增速
-56.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $7.2M | $5.2M |
| 净利润 | — | $717.5M |
| 毛利率 | — | -7850.0% |
| 营业利润率 | — | — |
| 净利率 | — | 13798.1% |
| 营收同比 | -68.4% | 405.9% |
| 净利润同比 | 3.1% | 436.6% |
| 每股收益（稀释后） | — | $10.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARCTVAL
| Q4 25 | $7.2M | $5.2M | ||
| Q3 25 | $17.2M | $5.6M | ||
| Q2 25 | $28.3M | $700.0K | ||
| Q1 25 | $29.4M | — | ||
| Q4 24 | $22.8M | $-1.7M | ||
| Q3 24 | $41.7M | $3.9M | ||
| Q2 24 | $49.9M | $4.8M | ||
| Q1 24 | $38.0M | $2.6M |
净利润ARCTVAL
| Q4 25 | — | $717.5M | ||
| Q3 25 | $-13.4M | $188.1M | ||
| Q2 25 | $-9.2M | $115.1M | ||
| Q1 25 | $-14.1M | — | ||
| Q4 24 | $-30.0M | $133.7M | ||
| Q3 24 | $-6.9M | $64.6M | ||
| Q2 24 | $-17.2M | $149.6M | ||
| Q1 24 | $-26.8M | $25.5M |
毛利率ARCTVAL
| Q4 25 | — | -7850.0% | ||
| Q3 25 | — | -7142.9% | ||
| Q2 25 | — | -56428.6% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 24529.4% | ||
| Q3 24 | — | -11748.7% | ||
| Q2 24 | — | -9039.6% | ||
| Q1 24 | — | -17007.7% |
营业利润率ARCTVAL
| Q4 25 | — | — | ||
| Q3 25 | -96.3% | — | ||
| Q2 25 | -41.0% | — | ||
| Q1 25 | -57.3% | — | ||
| Q4 24 | -146.7% | — | ||
| Q3 24 | -25.8% | — | ||
| Q2 24 | -42.4% | — | ||
| Q1 24 | -80.0% | — |
净利率ARCTVAL
| Q4 25 | — | 13798.1% | ||
| Q3 25 | -78.4% | 3358.9% | ||
| Q2 25 | -32.4% | 16442.9% | ||
| Q1 25 | -47.9% | — | ||
| Q4 24 | -131.8% | -7864.7% | ||
| Q3 24 | -16.6% | 1656.4% | ||
| Q2 24 | -34.5% | 3116.7% | ||
| Q1 24 | -70.5% | 980.8% |
每股收益（稀释后）ARCTVAL
| Q4 25 | — | $10.13 | ||
| Q3 25 | $-0.49 | $2.65 | ||
| Q2 25 | $-0.34 | $1.61 | ||
| Q1 25 | $-0.52 | — | ||
| Q4 24 | $-1.10 | $1.86 | ||
| Q3 24 | $-0.26 | $0.88 | ||
| Q2 24 | $-0.64 | $2.03 | ||
| Q1 24 | $-1.00 | $0.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $230.9M | $599.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $214.0M | $3.2B |
| 总资产 | $271.1M | $5.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ARCTVAL
| Q4 25 | $230.9M | $599.4M | ||
| Q3 25 | $180.4M | $662.7M | ||
| Q2 25 | $196.5M | $503.4M | ||
| Q1 25 | $216.9M | — | ||
| Q4 24 | $237.0M | $368.2M | ||
| Q3 24 | $237.2M | $379.3M | ||
| Q2 24 | $260.3M | $398.3M | ||
| Q1 24 | $288.4M | $494.1M |
股东权益ARCTVAL
| Q4 25 | $214.0M | $3.2B | ||
| Q3 25 | $224.6M | $2.4B | ||
| Q2 25 | $231.1M | $2.3B | ||
| Q1 25 | $233.8M | — | ||
| Q4 24 | $241.0M | $2.2B | ||
| Q3 24 | $261.9M | $2.1B | ||
| Q2 24 | $258.6M | $2.2B | ||
| Q1 24 | $264.0M | $2.0B |
总资产ARCTVAL
| Q4 25 | $271.1M | $5.3B | ||
| Q3 25 | $282.3M | $4.6B | ||
| Q2 25 | $309.3M | $4.5B | ||
| Q1 25 | $331.8M | — | ||
| Q4 24 | $344.1M | $4.4B | ||
| Q3 24 | $370.7M | $4.3B | ||
| Q2 24 | $388.6M | $4.4B | ||
| Q1 24 | $418.8M | $4.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-74.3M | $72.2M |
| 自由现金流经营现金流 - 资本支出 | $-74.5M | $-34.1M |
| 自由现金流率自由现金流/营收 | -1035.2% | -655.8% |
| 资本支出强度资本支出/营收 | 3.2% | 2044.2% |
| 现金转化率经营现金流/净利润 | — | 0.10× |
| 过去12个月自由现金流最近4个季度 | — | $159.9M |
8季度趋势，按日历期对齐
经营现金流ARCTVAL
| Q4 25 | $-74.3M | $72.2M | ||
| Q3 25 | $-17.2M | $198.1M | ||
| Q2 25 | $-5.8M | $120.0M | ||
| Q1 25 | $-35.1M | — | ||
| Q4 24 | $-284.0K | $124.6M | ||
| Q3 24 | $-23.8M | $193.0M | ||
| Q2 24 | $-30.1M | $11.5M | ||
| Q1 24 | $-5.6M | $26.3M |
自由现金流ARCTVAL
| Q4 25 | $-74.5M | $-34.1M | ||
| Q3 25 | $-17.3M | $128.3M | ||
| Q2 25 | — | $52.8M | ||
| Q1 25 | $-35.3M | — | ||
| Q4 24 | — | $12.9M | ||
| Q3 24 | $-23.8M | $111.1M | ||
| Q2 24 | $-30.5M | $-98.7M | ||
| Q1 24 | $-5.8M | $-125.0M |
自由现金流率ARCTVAL
| Q4 25 | -1035.2% | -655.8% | ||
| Q3 25 | -101.1% | 2291.1% | ||
| Q2 25 | — | 7542.9% | ||
| Q1 25 | -120.1% | — | ||
| Q4 24 | — | -758.8% | ||
| Q3 24 | -57.2% | 2848.7% | ||
| Q2 24 | -61.1% | -2056.3% | ||
| Q1 24 | -15.3% | -4807.7% |
资本支出强度ARCTVAL
| Q4 25 | 3.2% | 2044.2% | ||
| Q3 25 | 1.1% | 1246.4% | ||
| Q2 25 | 0.0% | 9600.0% | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.0% | -6570.6% | ||
| Q3 24 | 0.2% | 2100.0% | ||
| Q2 24 | 0.7% | 2295.8% | ||
| Q1 24 | 0.6% | 5819.2% |
现金转化率ARCTVAL
| Q4 25 | — | 0.10× | ||
| Q3 25 | — | 1.05× | ||
| Q2 25 | — | 1.04× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.93× | ||
| Q3 24 | — | 2.99× | ||
| Q2 24 | — | 0.08× | ||
| Q1 24 | — | 1.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
